Australian Pharma Stock News

PDI Gold (ASX:PDI) is in focus after shareholders approved a name change from Predictive Discovery and a five for one share consolidation, marking a structural shift that can reshape how investors assess the stock. The A$4.61 share price sits against a backdrop of strong recent momentum, with a 30 day share price return of 36.59% and a year to date share price return of 26.30%. The 1 year total shareholder return of 94.11% and very large 5 year total shareholder return suggest the PDI Gold...

PLS Group (ASX:PLS) has drawn fresh attention after releasing full year 2026 results alongside a fully franked final dividend. Investors are weighing the stronger earnings profile, higher production volumes, and new capital return details. Over the past year, interest in PLS Group has been reflected in both the share price and income returns. The 1 year total shareholder return of 126.07% far exceeds the year to date share price return of 22.74%, with recent momentum supported by a 24.47% 1...

As the Australian market absorbs recent Consumer Price Index figures and contemplates potential interest rate changes, investors are keenly observing opportunities in various sectors. Penny stocks, despite their somewhat outdated name, continue to attract attention as they represent smaller or newer companies with potential for significant value. By focusing on those with strong financials and growth prospects, investors can uncover promising opportunities among these lesser-known entities.

How GPT Group’s latest half year result reshaped the earnings picture GPT Group (ASX:GPT) attracted fresh attention after reporting half year earnings to 30 June 2026, with net income and earnings per share from continuing operations higher year on year despite lower reported revenue. The company posted sales of A$428.2 million compared with A$417.6 million a year earlier. Reported revenue was A$504.8 million against A$551.2 million, while net income rose to A$400.1 million from A$329.1...

McMillan Shakespeare Group (ASX: MMS) recently expanded its automotive ecosystem partnerships and reported 7% growth in novated leasing in the first half of FY26, supported by rising electric vehicle demand and government incentives. This push to deepen ties with global automotive brands and scale its integrated digital novated leasing platform could further entrench MMS as a central connector across manufacturers, dealers, financiers and customers. We’ll now explore how this acceleration in...

Charter Hall Group recently reported its full-year results to 30 June 2026, with sales of A$556.7 million, revenue of A$811.3 million, and net income of A$241.5 million, all higher than the prior year. The uplift in basic and diluted earnings per share from continuing operations suggests the business converted its growing revenue base into stronger profitability. We’ll now examine how this improvement in revenue and net income shapes Charter Hall Group’s existing investment narrative and...

SiteMinder walked into this result with a stock under pressure, down over 17% in the past week and sitting at A$3.11, even as revenue continued to climb. The headline today is not the top line; it is the shrinking loss. Management reported full year revenue of A$266.2m alongside a trailing twelve month loss of A$11.3m, which is smaller than in recent periods. The market is treating SiteMinder as an unprofitable software stock with execution risk, yet the earnings print leans more toward a...

Alkane Resources has reported discovery of a new high-grade gold‑antimony zone at the Cuffley Lode and strong Sub‑KC drilling results at Costerfield, alongside record FY26 revenue of A$935.82 million and net income of A$228.72 million. The company has paired these outcomes with its maiden fully franked 2.0 cent dividend, a buyback of up to 50,000,000 shares, and two new independent non-executive directors, signalling a shift toward capital returns and board expansion. We’ll now explore how...

Coles Group walked into this result with the stock up 11.7% over three months and trading on a rich P/E of 29.5%, priced as a dependable supermarket compounder. The headline today is that the earnings engine largely lived up to that premium. Full year underlying net profit after tax reached A$1.09b and group revenue came in at A$45.6b, with food supermarkets and a fast growing A$5.6b eCommerce arm doing the heavy lifting. Is Coles Group’s 29.5x P/E a justified premium for a supermarket...

Sims Limited recently reported full-year results to June 30, 2026, with sales of A$8,031.9 million and net income of A$245.3 million, and declared a fully franked A$0.20 per share dividend payable on October 15, 2026. The shift from a loss per share last year to earnings per share above A$1 highlights a major turnaround in profitability for the recycling group. We’ll now examine how this return to profitability and higher fully franked dividend could influence Sims’ investment narrative and...

Just because a business does not make any money, does not mean that the stock will go down. For example, Avecho...

Investors who take an interest in Judo Capital Holdings Limited ( ASX:JDO ) should definitely note that the Independent...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Investors who take an interest in Australian Finance Group Limited ( ASX:AFG ) should definitely note that the...

Market forces rained on the parade of IDP Education Limited ( ASX:IEL ) shareholders today, when the analysts...

SRG Global Limited (ASX:SRG) recently reported full-year 2026 results showing higher sales of A$1,675.5 million and net income of A$71.92 million, alongside declaring a fully franked second-half dividend of A$0.04 per share. Management also highlighted ongoing use of AI for operational decisions and a continued appetite for selective acquisitions to enhance SRG Global’s capabilities and footprint. We’ll now examine how SRG Global’s stronger earnings and higher dividend affect its...

Viewing insider transactions for Metals X Limited's ( ASX:MLX ) over the last year, we see that insiders were net...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Some Suncorp Group Limited ( ASX:SUN ) shareholders may be a little concerned to see that the CEO, MD & Executive...

Abacus Group stock closed at A$0.905 on Wednesday, only slightly higher over the past week, which suggests investors are still weighing up the full year 2026 result. The headline is an uncomfortable split personality. Funds From Operations, the key metric for a real estate investment trust, came in at A$81.2m and kept the operating engine steady. However, a one off A$122m non cash loss tied to the Storage King stake pushed statutory earnings deep into the red. Love the steady A$81.2m FFO from...

Central banks are weighing how to respond to energy price swings that keep inflation uncertain and real yields in focus. That puts reliable income front and center for many portfolios. Dividend Fortresses targets stocks that combine 5%+ yields with a focus on durability when policy paths feel unclear. This article highlights three Dividend Fortresses stocks that illustrate how investors use this kind of screen to anchor long term income planning. The three Dividend Fortresses in this article...

Navigator Global Investments Limited’s recent full-year 2026 results showed revenue rising to US$417.72 million from US$365.79 million, while net income fell to US$21.2 million from US$119.36 million and diluted earnings per share from continuing operations came in at US$0.0363. Alongside these mixed results, management outlined plans for measured acquisitive growth in Fiscal Year 2027, highlighting a robust pipeline of established, differentiated partner firms aimed at further diversifying...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Global healthcare spending from governments remains in focus as China directs more public budget towards healthcare and social security. That kind of policy support can help AI healthcare companies find customers who are under pressure to cut costs and improve care quality at the same time. This article looks at 3 transformative AI healthcare stocks from our screener that aim to benefit from this long term shift. The three stocks below are just a starting sample from this AI healthcare theme,...